| 5G48: reference: Targeting the beta-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal., Pandey P, Verma V, Gautam G, Kumari N, Dhar SK, Gourinath S, FEBS Lett. 2017 Aug;591(15):2311-2322. doi: 10.1002/1873-3468.12734. Epub 2017, Jul 26. PMID: 28656718 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).